Top
image credit: Pxhere

US scientists develop blood test to identify lymphoma prognosis

October 7, 2019

The test, created by scientists from Northwestern Medicine and the University of Chicago, identify if a patient with lymphoma will relapse after receiving treatment, predicting their survival time.

On a molecular level, the test identifies the type of tumour the patient is suffering, indicating how long the patient might live or respond to treatment in a better way.

Northwestern University Feinberg School of Medicine associate professor of cancer epidemiology and prevention Wei Zhang said: “Lymphoma represents an increasingly important health issue in the United States, so developing novel approaches for precise care of these patients will improve patients’ clinical outcomes and life quality.”

Read More on medicaldevice-network.com